Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gallbladder Neoplasms × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Transitional Cell 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

Gemcitabine 4 Cisplatin 4 pembrolizumab 3 durvalumab 2 Oxaliplatin 2 Capecitabine 2 zanidatamab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tivozanib 1 fludarabine 1 atezolizumab 1 aldesleukin 1 Trastuzumab 1 Tegafur 1 Taxes 1 Specimen Handling 1 S 1 (combination) 1 Platinum 1 Observation 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Ipilimumab 1 Interleukin-2 1 Fluorouracil 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡